《滬深兩市》上證深成高開0.3%-0.4% 藥明康德續升逾2%
內地昨日(15日)新增本土確診病例46例。人行今日(16日)進行100億元人民幣(下同) 7天期逆回購操作,利率持平。內地外匯佔款連升五個月,人民幣兌美元中間價今上調142點。上證深成創板均高開。
上證綜指高開0.3%或10點,開報3,457點;深証成指高開58點或0.4%,開報13,403點;滬深300高開19點或0.4%,開報4,619;創業板指高開13點或0.5%,報2,829點。
中資金融股未有明顯方向,工行(601398.SH)高開0.2%。建行(601939.SH)平開。
中移動(00941.HK)(600941.SH)公布,昨日再回購232.95萬股H股或已發行股本0.011%,涉資1.27億港元。中移動A股今早開市升0.6%。
藥明康德(603259.SH)去年淨利潤按年增72.19%,股價開市續升2.4%。
寧德時代(300750.SZ)董事長曾毓群表示,未來公司擬加強海外基地佈局,美國市場是一定要進的,該股今早開市升0.2%。(ta/k) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.